Market veteran Ambareesh Baliga suggests pharmaceutical stocks offer a safe haven amidst currency volatility and cautious foreign investor sentiment. He advises focusing on top-tier pharma companies. Baliga also expresses caution on jewellery stocks due to increased gold import duties and anticipates margin pressures, while maintaining a positive outlook on Tata Motors and a bullish long-term view on Solar Industries India.
Recent Posts
- Crypto traders betting on a rally lose $563 million in liquidations. Ether and bitcoin suffer the most
- Ryanair has plans for ‘armageddon’ scenario as CFO warns weaker European carriers may not survive jet fuel crunch
- Stock Market Crash News Today Live Updates: Nifty Reclaims 23,450, Sensex Gains 500 Points From Day’s Low; IT Stands Out As Only Sectoral Gainer
- Cochin Shipyard Shares Tumble 7% As Kotak Eyes 43% Downside After Q4 Profit Drop: Buy Or Sell?
- Messi Fiasco: New BJP Govt In Bengal Orders Probe, Says Event Tickets May Be Refunded